201 related articles for article (PubMed ID: 6933259)
1. Effect of age on antipyrine metabolism in patients with gastric cancer.
Higuchi T; Nakamura T; Uchino H
J Natl Cancer Inst; 1980 Nov; 65(5):897-900. PubMed ID: 6933259
[TBL] [Abstract][Full Text] [Related]
2. Metabolic disposition of antipyrine in patients with lung cancer.
Tschanz C; Hignite CE; Huffman DH; Azarnoff DL
Cancer Res; 1977 Nov; 37(11):3881-6. PubMed ID: 908027
[TBL] [Abstract][Full Text] [Related]
3. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
[TBL] [Abstract][Full Text] [Related]
4. Microsomal enzymes in patients with gastric carcinoma as determined by plasma half-life of antipyrine.
Higuchi T; Nakamura T; Uchino H
Gan; 1978 Dec; 69(6):753-6. PubMed ID: 750270
[TBL] [Abstract][Full Text] [Related]
5. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
Vesell ES; Page JG
J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
[TBL] [Abstract][Full Text] [Related]
6. Impairment of drug elimination in patients with liver disease.
Narang AP; Datta DV; Mathur VS
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
[TBL] [Abstract][Full Text] [Related]
7. Changes in salivary antipyrine pharmacokinetics during adolescence, correlated with age, hormonal levels and Tanner stage.
Linday LA; Greenblatt DJ; Warren MP; Harmatz JS; DeCresce R; Cicalese C; LeDuc BW
Dev Pharmacol Ther; 1991; 16(4):194-202. PubMed ID: 1782837
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antipyrine metabolism in cigarette smokers in Indian population.
Uppal R; Garg SK; Sharma PR; Nair CR; Chaudhury RR
Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):269-71. PubMed ID: 7450928
[TBL] [Abstract][Full Text] [Related]
9. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
[TBL] [Abstract][Full Text] [Related]
10. Antipyrine metabolism and bronchogenic carcinoma.
Ambre J; Graeff D; Bures F; Haupt D; Deason K
J Med; 1977; 8(1):57-70. PubMed ID: 267157
[TBL] [Abstract][Full Text] [Related]
11. Antipyrine kinetics in Nigerian women in chronic renal failure.
Iyun AO; Tucker GT
Afr J Med Med Sci; 1982 Mar; 11(1):7-9. PubMed ID: 6291357
[TBL] [Abstract][Full Text] [Related]
12. Antipyrine metabolism in lung cancer patients and their relatives.
Radzikowska E; Gazdzik W; Rowińska-Zakrzewska E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():297-308. PubMed ID: 9337547
[TBL] [Abstract][Full Text] [Related]
13. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
Teunissen MW; De Leede LG; Boeijinga JK; Breimer DD
J Pharmacol Exp Ther; 1985 Jun; 233(3):770-5. PubMed ID: 4009489
[TBL] [Abstract][Full Text] [Related]
14. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
[TBL] [Abstract][Full Text] [Related]
15. Oxazepam kinetics: effects of age and sex.
Greenblatt DJ; Divoll M; Harmatz JS; Shader RI
J Pharmacol Exp Ther; 1980 Oct; 215(1):86-91. PubMed ID: 7452494
[TBL] [Abstract][Full Text] [Related]
16. On the regulation of antipyrine and oxazepam metabolism in man.
Kellermann GH; Luyten-Kellermann M
Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):287-96. PubMed ID: 461954
[TBL] [Abstract][Full Text] [Related]
17. Ketoconazole does not impair antipyrine clearance in humans.
Blyden GT; Abernethy DR; Greenblatt DJ
Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):225-6. PubMed ID: 3733272
[TBL] [Abstract][Full Text] [Related]
18. The kinetics of induction by rifampin of alpha 1-acid glycoprotein and antipyrine clearance in the dog.
Abramson FP; Lutz MP
Drug Metab Dispos; 1986; 14(1):46-51. PubMed ID: 2868864
[TBL] [Abstract][Full Text] [Related]
19. Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking.
Vestal RE; Norris AH; Tobin JD; Cohen BH; Shock NW; Andres R
Clin Pharmacol Ther; 1975 Oct; 18(4):425-32. PubMed ID: 1164824
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of metabolic efficiency of the liver in patients with psoriasis by the antipyrine test].
Bienias L; Czarnecki M; Kaszuba A; Ruszczak Z; Kozłowska M; Bednarowicz G; Drobnik G
Przegl Dermatol; 1990; 77(5):301-6. PubMed ID: 2270292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
